179 related articles for article (PubMed ID: 24432241)
1. A case of Exophiala oligosperma successfully treated with voriconazole.
Rimawi BH; Rimawi RH; Mirdamadi M; Steed LL; Marchell R; Sutton DA; Thompson EH; Wiederhold NP; Lindner JR; Boger MS
Med Mycol Case Rep; 2013 Sep; 2():144-7. PubMed ID: 24432241
[TBL] [Abstract][Full Text] [Related]
2. Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis.
Noguchi H; Matsumoto T; Kimura U; Hiruma M; Kano R; Yaguchi T; Kubo M; Kashiwada-Nakamura K; Fukushima S
J Dermatol; 2022 May; 49(5):564-571. PubMed ID: 35218073
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous Phaeohyphomycosis Caused by Exophiala oligosperma in an Immunocompetent Host: Case Report and Literature Review.
Yang H; Cai Q; Gao Z; Lv G; Shen Y; Liu W; Yang L
Mycopathologia; 2018 Oct; 183(5):815-820. PubMed ID: 29946995
[TBL] [Abstract][Full Text] [Related]
4. Species diversity, antifungal susceptibility and phenotypic and genotypic characterisation of Exophiala spp. infecting patients in different medical centres in Brazil.
Silva WC; Gonçalves SS; Santos DW; Padovan AC; Bizerra FC; Melo AS
Mycoses; 2017 May; 60(5):328-337. PubMed ID: 28139861
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.
Sun Y; Liu W; Wan Z; Wang X; Li R
Mycopathologia; 2011 Feb; 171(2):111-7. PubMed ID: 20803255
[TBL] [Abstract][Full Text] [Related]
6. Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature.
Rimawi RH; Carter Y; Ware T; Christie J; Siraj D
Mycopathologia; 2013 Apr; 175(3-4):345-9. PubMed ID: 23334554
[TBL] [Abstract][Full Text] [Related]
7. A case of phaeohyphomycosis caused by Exophiala oligosperma successfully treated with local hyperthermia.
Fukai T; Hiruma M; Ogawa Y; Ikeda S; Ikeda H; Sano A; Makimura K
Med Mycol J; 2013; 54(3):297-301. PubMed ID: 23995420
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous phaeohyphomycosis due to Exophiala jeanselmei following renal transplantation: A case report with a published work review of phaeohyphomycosis in Japan.
Takenaka M; Murota H; Nishimoto K
J Dermatol; 2020 Sep; 47(9):1050-1053. PubMed ID: 32515042
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Exophiala oligosperma Infection in a Patient with Bullous Pemphigoid with a Review of the Literature.
Ng CY; de Hoog S; Li HE; Lee YY; Chen CB; Sun PL
Mycopathologia; 2017 Jun; 182(5-6):539-547. PubMed ID: 28025758
[TBL] [Abstract][Full Text] [Related]
10. Phaeohyphomycosis Due to
Nishikawa H; Taniguchi Y
J Rheumatol; 2019 Jun; 46(6):652. PubMed ID: 31154445
[No Abstract] [Full Text] [Related]
11. A rare case report of subcutaneous phaeohyphomycotic cyst caused by Exophiala oligosperma in an immunocompetent host with literature review.
Venkateshwar S; Ambroise MM; Asir GJ; Mudhigeti N; Ramdas A; Authy K; Shivaprakash MR; Kanungo R
Mycopathologia; 2014 Aug; 178(1-2):117-21. PubMed ID: 24902578
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Seneviratne CJ; Fong PH; Wong SS; Lee VH
BMC Oral Health; 2015 Mar; 15():39. PubMed ID: 25887752
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous phaeohyphomycosis caused by Exophiala oligosperma.
Lucas-Truyols S; Sabater-Abad J; Navarro-Pérez L; Jiménez-Sánchez AI
Med Clin (Barc); 2019 Jan; 152(2):82. PubMed ID: 29747870
[No Abstract] [Full Text] [Related]
14. Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
Calvo E; Pastor FJ; Guarro J
J Antimicrob Chemother; 2010 Jul; 65(7):1455-9. PubMed ID: 20488983
[TBL] [Abstract][Full Text] [Related]
15. [Human infections by black yeasts of genus Exophiala].
García-Martos P; Márquez A; Gené J
Rev Iberoam Micol; 2002 Jun; 19(2):72-9. PubMed ID: 12828507
[TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species.
Badali H; Najafzadeh MJ; van Esbroeck M; van den Enden E; Tarazooie B; Meis JF; de Hoog GS
Med Mycol; 2010 Mar; 48(2):318-27. PubMed ID: 19642051
[TBL] [Abstract][Full Text] [Related]
17. Clinical Spectrum, Molecular Characterization, Antifungal Susceptibility Testing of
Singh S; Rudramurthy SM; Padhye AA; Hemashetter BM; Iyer R; Hallur V; Sharma A; Agnihotri S; Gupta S; Ghosh A; Kaur H
Front Cell Infect Microbiol; 2021; 11():686120. PubMed ID: 34277470
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous phaeohyphomycosis caused by Exophiala oligosperma in a renal transplant recipient.
González-López MA; Salesa R; González-Vela MC; Fernández-Llaca H; Val-Bernal JF; Cano J
Br J Dermatol; 2007 Apr; 156(4):762-4. PubMed ID: 17263805
[No Abstract] [Full Text] [Related]
19. Phaeohyphomycosis caused by Exophiala species in immunocompromised hosts.
Liou JM; Wang JT; Wang MH; Wang SS; Hsueh PR
J Formos Med Assoc; 2002 Jul; 101(7):523-6. PubMed ID: 12353348
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Exophiala dermatitidis causing septic arthritis and osteomyelitis.
Lang R; Minion J; Skinner S; Wong A
BMC Infect Dis; 2018 Jun; 18(1):255. PubMed ID: 29866071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
